TROVIS PHARMACEUTICALS, LLC
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 08, 2013 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 466 Total Citation Count
- Mar 31, 2004 Earliest Filing
- 21 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8222228 Substituted aryl piperidinylalkynyladenosines as A2AR agonistsExpiredDec 29, 10Jul 17, 12[A61K, A01N]
2011/0082,157 Piperidinylamino-Thieno [2,3-D] Pyrimidine CompoundsAbandonedJun 08, 10Apr 07, 11[A61K, C07D, A61P]
2010/0280,050 Piperidinylamino-Thieno[2,3-D] Pyrimidine Compounds for Treating FibrosisAbandonedSep 04, 08Nov 04, 10[A61K, A61P]
2010/0113,485 Piperidinylamino-thieno[2,3-D] Pyrimidine CompoundsAbandonedOct 30, 09May 06, 10[A61K, C07D, A61P]
7612078 Piperidinylamino-thieno[2,3-D] pyrimidine compoundsExpiredMar 08, 05Nov 03, 09[A61K, C07D, A61P]
7589076 Substituted aryl piperidinylalkynyladenosines as A2AR agonistsExpiredMay 17, 07Sep 15, 09[A61K, A01N]
2009/0181,920 INTRATHECAL TREATMENT OF NEUROPATHIC PAIN WITH A2AR AGONISTSAbandonedJan 09, 09Jul 16, 09[A61K, A61P]
7470697 Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A.sub.2B adenosine receptorsExpiredAug 31, 07Dec 30, 08[C07D]
2008/0262,001 AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH IN THE LIVER FOLLOWING RESECTIONAbandonedApr 14, 08Oct 23, 08[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.